Prices delayed by at least 15 minutes | Print
Cellbxhealth PLC (CLBX)
ORD 0.05POpen
0.60p
Previous close
0.60p
Trade high
0.649p
Volume
698,644
Year high
2.80p
Year low
0.533p
Dividend yield
–
Market capitalisation
£6.82 mn
P/E ratio
–
ISIN
GB0034330679
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
CelLBxHealth PLC is engaged in the development and commercialisation of the Parsortix platform, with deployment in liquid biopsy - non-invasive cancer diagnostics. It operates in single segment of commercialisation of its Parsortix cell separation platform. It generates revenue from contracts with customers in the research-use market, with customers located across multiple geographic regions. Geographically it operates in UK, Europe, North America, and Rest of World with majority of revenue deriving from Europe and North America.
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 13/11/2026 | 04:07:25 | 0.649 | 100,000 | 649.00 |
| 13/11/2026 | 03:37:50 | 0.6156 | 100 | 0.62 |
| 13/11/2026 | 03:34:21 | 0.6156 | 174,825 | 1,076.22 |
| 13/11/2026 | 02:11:44 | 0.55 | 426 | 2.34 |
| 13/11/2026 | 11:56:41 | 0.6156 | 100,000 | 615.60 |